PATENT CLAIM ANALYSIS

Application Number: 16179050
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["540", "555000"]

Abstract:
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C  receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C  receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C  receptor.

Claim (Index 53):
The compound as claimed in any of  claims 1  to  50  or an N-oxide, a tautomeric form, a stereoisomer or a pharmaceutically acceptable salt thereof for the treatment of disorders which respond to the modulation of the 5-HT 2C  receptor.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.88636
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13838788', '14657840', '14657916', '14026354', '14868835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7340373475201459
- 35 USC 102 Novelty (BERT): 0.605088500453754
- Combined Prediction Score: 0.7211424628135068
- Mean Citation Score: 483.115398
- Max Citation Score: 558.0024
- Similarity Product: 436.0857169532776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test